Acasti Pharma Inc. (CVE:ACST – Get Free Report)’s stock price rose 1.8% on Thursday . The stock traded as high as C$0.58 and last traded at C$0.58. Approximately 2,450 shares were traded during trading, a decline of 63% from the average daily volume of 6,576 shares. The stock had previously closed at C$0.57.
Acasti Pharma Stock Up 1.8 %
The firm’s fifty day simple moving average is C$0.58 and its 200-day simple moving average is C$0.58. The company has a market cap of C$18.19 million, a PE ratio of -1.21 and a beta of 1.22.
Acasti Pharma Company Profile
Acasti Pharma Inc, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
See Also
- Five stocks we like better than Acasti Pharma
- The Basics of Support and Resistance
- Conagra Stock Could Thrive as Tariffs Hit Other Sectors
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Grocery Costs and Tariffs Now Top of Mind in Everyday Conversations, New Survey Finds
- How is Compound Interest Calculated?
- Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?
Receive News & Ratings for Acasti Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acasti Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20230215195954&h=45&w=95&zc=2){kind=logo}
